Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's-Reference-Cited by-同舟云学术

Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's

Published:2021-08 Issue: Volume:107 Page:106488
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Butler Tracy,Goldberg Judith D.,Galvin James E.,Maloney Thomas,Ravdin Lisa,Glodzik Lidia,de Leon Mony J.,Hochman Tsivia,Bowen Richard L.,Atwood Craig S.

Funder

National Institutes of Health

National Institute on Aging

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference72 articles.

1. Donepezil for dementia due to Alzheimer's disease;Birks;Cochrane Database Syst Rev,2018

2. Solanezumab and the amyloid hypothesis for Alzheimer’s disease;Le Couteur,2016

3. The contributions of unscheduled neuronal cell cycle events to the death of neurons in Alzheimer's disease;Herrup;Front Biosci.,2012

4. The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease;Atwood;Horm. Behav.,2015

5. A unified hypothesis of early- and late-onset Alzheimer’s disease pathogenesis;Atwood;J. Alzheimer’s Dis.,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocrine Dyscrasia in the Etiology and Therapy of Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-09-04

2. CD4+ T-Cell Senescence in Neurodegenerative Disease: Pathogenesis and Potential Therapeutic Targets;Cells;2024-04-25

3. Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies;Medicinal Research Reviews;2024-03-26

4. Cancer drugs with high repositioning potential for Alzheimer’s disease;Expert Opinion on Emerging Drugs;2023-10-02

5. Mechanisms linking neurological disorders with reproductive endocrine dysfunction: Insights from epilepsy research;Frontiers in Neuroendocrinology;2023-10